Previous 10 | Next 10 |
home / stock / ctabf / ctabf news
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the " Company " or " Canntab "), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engag...
Toronto, Ontario--(Newsfile Corp. - February 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the " Company " or " Canntab ") announces that it has granted, in accordance with the Company's stock option plan, an aggregate of 50,000 options to purchase common sh...
Canntab Therapeutics ([[CTABF]]) announces that the Canadian Intellectual Property Office has allowed Canadian Patent No. CA 3050150 to Canntab, related to its proprietary cannabidiol formulations.The company has filed more than a dozen patent applications in the United States ...
Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets Canada NewsWire TORONTO , Feb. 1, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the " Company " or " Canntab "), a leading innovator ...
Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...
Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...
Toronto, Ontario--(Newsfile Corp. - December 31, 2020) - Canntab Therapeutics Limited. (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) ("Canntab" or the "Company") , the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to anno...
Canntab Begins Delivery of Tablets to MediPharm PR Newswire TORONTO, Dec. 1, 2020 TORONTO , Dec. 1, 2020 /PRNewswire/ - Canntab Therapeutics Limited ( CSE:PILL.CN ) ( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " Company " or " Canntab "), the ...
Toronto, Ontario--(Newsfile Corp. - November 16, 2020) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company" or "Canntab "), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces that Canntab an...
Delta, Kelowna, BC - October 27, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus ins...
News, Short Squeeze, Breakout and More Instantly...
Canntab Therapeutics Ltd Company Name:
CTABF Stock Symbol:
OTCMKTS Market:
Canntab Therapeutics Ltd Website:
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the " Corporation ") announces that the Ontario Securities Commission (the " OSC ") has rejected the Corporation's application for a management cease trade order (the ...
TORONTO, ON / ACCESSWIRE / November 22, 2022 / Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impac...
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabi...